W ith cases documented in more than 170 countries, the global swine f lu pandemic that erupted in spring 2009 remains a serious public health problem. Caused by a strain of H1N1 influenza virus, which is normally found in pigs, the flu now known as novel H1N1 has so far been less severe than regular seasonal flu in terms of deaths and hospitalizations. Yet given its remarkable capacity for huma...

The recent global outbreak of human cases of swine origin influenza A (H1N1) has spread fear that this virus will be of pandemic proportions causing high morbidity and mortality. While it is too early to determine the pandemic nature of swine origin influenza A (H1N1), it may be useful to look at the history of influenza pandemics described since recorded history. The first well-documented outb...

Background: Swine flu has become a life-threatening disease involving two main proteins neuraminidase (NA) and hemagglutinin (HA). Inhibition of NA, the protein responsible for initiation viral infection is important treatment step in eradication swine flu. In silico analysis natural compounds serves as lead drug development. Objective: The aim this study to obtain 3 dimensional structure (HIN1...

Numerous resources relevant to the 2009 pandemic influenza are available on-line . A casual search in google using the phrase "swine flu resources" yields 9,180,000 items making a time-bound search less fruitful for an average health care professional. This review has summarized the contents useful to practicing clinician available in 12 websites which were selected based on their relevance to ...

The prevalence of myocardial involvement in influenza infection ranges from 0% to 12%. The 2009 pH1N1 influenza virus, formerly known as swine flu, first appeared in Mexico and the United States of America in March and April 2009 and has swept the globe with unprecedented speed. We report a case of fulminant myocarditis associated with this virus treated successfully using extra-corporal membra...